ICON plc.

back to Directory

ICON plc.

ICON plc. logo

Founded
1990

Publications
398

ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. We specialise in the strategic development, management and analysis of programs that support Clinical Development - from compound selection to Phase I-IV clinical studies.

SpecialtiesMedical Device, Therapeutics, Government and Public Health Solutions, Clinical Research Services, Commercialisation and Outcomes, Oncology, Value Based Healthcare, Clinical Trials, Patient Recruitment, Innovation, Regulatory Affairs, Strategic Consulting, Medical Affairs, and Global Patient Insights & Engagement

Label: pharma R&D outsourcing

Posts Mentioning This Company

Marking the Path Ahead: Integrating Oncology Biomarkers Into Clinical Development

In recent years, therapeutic capabilities in oncology have grown dramatically, with a vast array of advanced treatments progressing through clinical trials and onto the market. However, there has been a lag between the development of promising precision treatments and the identification, development and implementation of biomarkers that identify patients most …

Combination Therapies May Be the Future of Oncology – How Can We Navigate Development Challenges Today?

The field of oncology is experiencing a proliferation of cancer therapies. In 2024 alone, the U.S. Food and Drug Administration (FDA) issued more than 60 oncology approvals, including 11 for first-in-class therapeutics.1 This diverse array of increasingly specialized treatments is reshaping the oncology market and ushering in a more diversified …